These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 36637750)

  • 1. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
    Sun Y; Sun F; Xu W; Qian H
    Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Extracellular Vesicles for Cancer Therapy.
    Zhang X; Zhang H; Gu J; Zhang J; Shi H; Qian H; Wang D; Xu W; Pan J; Santos HA
    Adv Mater; 2021 Apr; 33(14):e2005709. PubMed ID: 33644908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of engineered extracellular vesicles for targeted tumor therapy.
    Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X
    J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
    Wu M; Wang M; Jia H; Wu P
    Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications.
    Lee CS; Lee M; Na K; Hwang HS
    Mol Pharm; 2023 Nov; 20(11):5278-5311. PubMed ID: 37867343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in therapeutic engineered extracellular vesicles.
    Yao C; Zhang H; Wang C
    Nanoscale; 2024 Apr; 16(16):7825-7840. PubMed ID: 38533676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
    Liu Q; Li D; Pan X; Liang Y
    J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
    Ahmadi M; Hassanpour M; Rezaie J
    Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Therapy Empowered by Extracellular Vesicle-Mediated Targeted Delivery.
    Chen Y; Huang Y; Deng Y; Liu X; Ye J; Li Q; Luo Y; Lin Y; Liang R; Wei J; Zhang J; Li Y
    Biol Pharm Bull; 2023; 46(10):1353-1364. PubMed ID: 37779037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles for improved tumor accumulation and penetration.
    Bie N; Yong T; Wei Z; Gan L; Yang X
    Adv Drug Deliv Rev; 2022 Sep; 188():114450. PubMed ID: 35841955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles in cancer therapy: Roles, potential application, and challenges.
    Liu T; Sun L; Ji Y; Zhu W
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189101. PubMed ID: 38608963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications.
    Wang L; Wang D; Ye Z; Xu J
    Adv Sci (Weinh); 2023 Jun; 10(17):e2300552. PubMed ID: 37080941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy.
    Ruan S; Greenberg Z; Pan X; Zhuang P; Erwin N; He M
    Adv Healthc Mater; 2022 Mar; 11(5):e2100650. PubMed ID: 34197051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
    Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
    Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles: A bright star of nanomedicine.
    Wu P; Zhang B; Ocansey DKW; Xu W; Qian H
    Biomaterials; 2021 Feb; 269():120467. PubMed ID: 33189359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic regulation of extracellular vesicles: Implications for cancer therapy.
    Yoo S; Choi S; Kim I; Kim IS
    J Control Release; 2023 Nov; 363():201-220. PubMed ID: 37739015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
    Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
    Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.